Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Arcutis Biotherapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ARQT
Nasdaq
8731
https://arcutis.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Arcutis Biotherapeutics Inc
Arcutis Appoints David Topper as Chief Financial Officer
- Apr 10th, 2024 12:00 pm
Are Medical Stocks Lagging AdaptHealth (AHCO) This Year?
- Apr 8th, 2024 1:40 pm
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Apr 5th, 2024 8:00 pm
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
- Apr 1st, 2024 11:00 am
Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference
- Mar 28th, 2024 12:00 pm
Arcutis Biotherapeutics, Inc. (ARQT) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
- Mar 19th, 2024 1:55 pm
Is Adverum Biotechnologies (ADVM) Stock Outpacing Its Medical Peers This Year?
- Mar 19th, 2024 1:40 pm
Wall Street Analysts See a 54.78% Upside in Arcutis Biotherapeutics, Inc. (ARQT): Can the Stock Really Move This High?
- Mar 18th, 2024 1:55 pm
Arcutis Promotes Todd Tucker to Chief Human Resources Officer
- Mar 11th, 2024 12:00 pm
Arcutis Presents Late-Breaking Data From INTEGUMENT-PED Phase 3 Trial of Roflumilast Cream 0.05% in Atopic Dermatitis in Children Ages 2 to 5 at the American Academy of Dermatology Annual Meeting
- Mar 10th, 2024 8:00 pm
New Research Reveals Genomic Profile of Seborrheic Dermatitis and Answers Key Questions on Immune Response and Skin Barrier Dysfunction
- Mar 9th, 2024 9:00 pm
Peabody Energy, Citi Trends, and More Stocks See Action From Activist Investors
- Mar 9th, 2024 12:33 am
Arcutis Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
- Mar 4th, 2024 9:00 pm
Arcutis Announces Acceptance of Late Breaking Abstract in Atopic Dermatitis Among Five New Topical Roflumilast Data Being Presented at the American Academy of Dermatology Annual Meeting
- Mar 4th, 2024 1:00 pm
Wall Street Analysts See a 58.85% Upside in Arcutis Biotherapeutics, Inc. (ARQT): Can the Stock Really Move This High?
- Mar 1st, 2024 2:55 pm
Is Arcutis Biotherapeutics (ARQT) Outperforming Other Medical Stocks This Year?
- Mar 1st, 2024 2:40 pm
Earnings Beat: Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
- Mar 1st, 2024 11:22 am
Arcutis to Present at the TD Cowen 44th Annual Health Care Conference
- Feb 29th, 2024 10:00 pm
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q4 2023 Earnings Call Transcript
- Feb 29th, 2024 4:33 pm
Need To Know: Analysts Are Much More Bullish On Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Revenues
- Feb 29th, 2024 11:02 am
Scroll